Company intelligence / Profile preview

Stellaromics

Natick, Massachusetts, United Statesstellaromics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Stellaromics has developed the Pyxa platform and related technologies to enable high-resolution 3D mapping of gene expression and molecular features within thick tissue samples. Early access users at leading academic centers have demonstrated its utility in neuroscience and oncology research. The company is transitioning from early access to commercial launch with strong investor backing.

Modalities: DevicePlatform (for spatial multiomics analysis)
Industry: Molecular Diagnostics

Partnerships

University of Glasgow – first European deployment for cancer diagnostics/translational oncology research

Beyond the preview

Go deeper on Stellaromics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stellaromics.

Explore the full profile